Neuropsychiatric effects of cocaine use disorders.

The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci (2008) 2.72

The validity of cocaine dependence subtypes. Addict Behav (2007) 1.28

Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration. CNS Neurol Disord Drug Targets (2010) 0.98

Ligand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulations. PLoS One (2013) 0.87

Plants as a source of butyrylcholinesterase variants designed for enhanced cocaine hydrolase activity. Chem Biol Interact (2012) 0.80

Brain perfusion in polysubstance users: relationship to substance and tobacco use, cognition, and self-regulation. Drug Alcohol Depend (2015) 0.77

Impact of cocaine abuse on HIV pathogenesis. Front Microbiol (2015) 0.76

Risky Decisions in a Lottery Task Are Associated with an Increase of Cocaine Use. Front Psychol (2016) 0.75

The impact of self-reported life stress on current impulsivity in cocaine dependent adults. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.75

Influence of the dopaminergic system, CREB, and transcription factor-κB on cocaine neurotoxicity. Braz J Med Biol Res (2013) 0.75

Socio-demographic Characteristics of Individuals with History of Crack Cocaine Use in the US General Population. Community Ment Health J (2015) 0.75

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry (2002) 10.34

Limbic activation during cue-induced cocaine craving. Am J Psychiatry (1999) 6.66

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry (2001) 5.16

Cellular and molecular mechanisms of drug dependence. Science (1988) 4.99

Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia (2001) 4.71

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37

Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A (1996) 4.31

Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse (1993) 4.13

Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry (2001) 3.84

Neural systems and cue-induced cocaine craving. Neuropsychopharmacology (2002) 3.50

Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry (2002) 3.22

Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J Neurosci (2003) 2.96

Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (1997) 2.94

The efficacy of preemployment drug screening for marijuana and cocaine in predicting employment outcome. JAMA (1990) 2.89

Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci (2002) 2.83

Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 2.75

Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res (2000) 2.58

Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med (1994) 2.57

Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci (1999) 2.35

Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry (1991) 2.17

Long-term frontal brain metabolic changes in cocaine abusers. Synapse (1992) 2.16

Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry (2001) 2.14

Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry (2002) 2.11

Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry (1991) 2.00

Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry (2002) 1.99

The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophr Bull (1999) 1.89

Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage (2003) 1.87

Inhibition of the amygdala: key to pathological states? Ann N Y Acad Sci (2003) 1.78

Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci (1999) 1.77

Agents in development for the management of cocaine abuse. Drugs (2004) 1.77

Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat (2001) 1.68

Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry (1990) 1.66

Prenatal cocaine exposure: effects on the development of school-age children. Neurotoxicol Teratol (1997) 1.64

A behavioral teratogenic model of the impact of prenatal cocaine exposure on arousal regulatory systems. Neurotoxicol Teratol (2002) 1.57

Mechanism of cocaine-induced hyperthermia in humans. Ann Intern Med (2002) 1.55

Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task. Schizophr Res (2005) 1.54

Cerebral atrophy in habitual cocaine abusers: a planimetric CT study. Neurology (1991) 1.54

Prevalence of recent cocaine use among motor vehicle fatalities in New York City. JAMA (1990) 1.52

Effects of crack cocaine on neurocognitive function. Psychiatry Res (1996) 1.51

Pharmacological treatment of cocaine dependence: a systematic review. Addiction (2002) 1.51

Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend (2002) 1.46

Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity. J Forensic Sci (1997) 1.43

Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav (2001) 1.41

Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse (1992) 1.39

The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci (1998) 1.38

Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci (1993) 1.37

Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci (1991) 1.36

Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend (2002) 1.35

Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology (2000) 1.34

A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry (1999) 1.33

Effects of concurrent use of alcohol and cocaine. Addiction (2002) 1.30

Neurological complications of drug abuse: pathophysiological mechanisms. Eur J Neurol (2000) 1.28

Cocaine-induced psychosis. J Clin Psychiatry (1991) 1.24

Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA (1998) 1.23

Neuroimaging in bipolar disorder. Bipolar Disord (2000) 1.21

Brain maturation may be arrested in chronic cocaine addicts. Biol Psychiatry (2002) 1.20

Alcohol dependence and simultaneous cocaine and alcohol use in cocaine-dependent patients. J Addict Dis (1994) 1.20

Resting regional cerebral blood flow and gambling task performance in cocaine-dependent subjects and healthy comparison subjects. Am J Psychiatry (2003) 1.15

Patterns of HIV risk and alcohol use among African-American crack abusers. Drug Alcohol Depend (2000) 1.12

Cardiovascular complications of cocaine. Chest (1995) 1.12

Perfusion abnormalities and decision making in cocaine dependence. Biol Psychiatry (2004) 1.11

Characteristics of cocaine-dependent patients who attempt suicide. Am J Psychiatry (2001) 1.10

Treatment of cocaine dependence and depression. Biol Psychiatry (2004) 1.10

Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend (1993) 1.09

Suicide attempts in major affective disorder patients with comorbid substance use disorders. J Clin Psychiatry (1999) 1.09

Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period. Am J Psychiatry (1992) 1.06

Cocaine abstinence symptomatology and treatment attrition. J Subst Abuse Treat (1999) 1.06

Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstet Gynecol (2002) 1.05

Risk factors for symptom exacerbation among treated patients with substance use disorders. Addiction (2002) 1.03

Applications of errorless learning for improving work performance in persons with schizophrenia. Am J Psychiatry (2002) 1.03

Neurovascular complications of cocaine. Acta Neurol Scand (1994) 1.03

Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav (2004) 1.02

Apathy syndrome in cocaine dependence. Psychiatry Res (2002) 1.01

Stroke associated with cocaine abuse--? N Y State J Med (1977) 1.01

Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients. Int J Neurosci (2001) 1.01

Cocaine-induced channelopathies: emerging evidence on the multiple mechanisms of sudden death. J Cardiovasc Pharmacol Ther (2002) 1.00

Dose-response effect of fetal cocaine exposure on newborn neurologic function. Pediatrics (1999) 1.00

The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend (2003) 1.00

Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med (1987) 0.99

Violent behaviors associated with cocaine use: possible pharmacological mechanisms. Int J Addict (1991) 0.99

Resting hand tremor in abstinent cocaine-dependent, alcohol-dependent, and polydrug-dependent patients. Alcohol Clin Exp Res (1996) 0.99

Drug abuse and bipolar disorder: comorbidity or misdiagnosis? J Affect Disord (2001) 0.99

Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine. Drug Alcohol Depend (2003) 0.98

Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med (2001) 0.98

Neuropsychologic findings in cocaine-dependent outpatients. Prog Neuropsychopharmacol Biol Psychiatry (1998) 0.97

Concurrent use of cocaine and alcohol by patients treated in the emergency department. Ann Emerg Med (1996) 0.96

Personality profile and neuropsychological test performance in chronic cocaine-abusers. Int J Neurosci (2001) 0.96

Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients. Psychiatr Serv (1998) 0.96

Gender differences in cerebral perfusion in cocaine abuse: technetium-99m-HMPAO SPECT study of drug-abusing women. J Nucl Med (1994) 0.96

Effects of chronic cocaine abuse on memory and learning. Arch Clin Neuropsychol (1993) 0.96

Epileptogenic properties of cocaine in humans. Neurotoxicology (1991) 0.95

Errorless learning and the cognitive rehabilitation of memory-impaired schizophrenic patients. Psychol Med (1999) 0.95

Cocaine and the critical care challenge. Crit Care Med (2003) 0.95

Limbic responsiveness to procaine in cocaine-addicted subjects. Am J Psychiatry (2001) 0.94

Cocaine-related symptoms in patients presenting to an urban emergency department. Ann Emerg Med (1991) 0.94

Selective direct toxicity of cocaine on fetal mouse neurons. Teratogenic implications of neurite and apoptotic neuronal loss. Ann N Y Acad Sci (1998) 0.93

Neuropsychological functioning in cocaine abusers with and without alcohol dependence. J Int Neuropsychol Soc (1999) 0.92

Alcoholics also dependent on cocaine in treatment: do they differ from "pure" alcoholics? Addict Behav (1994) 0.91

Cerebral perfusion defects in combined cocaine and alcohol dependence. Drug Alcohol Depend (2002) 0.91

Contribution of substance abuse and HIV infection to psychiatric distress in an inner-city African-American population. J Natl Med Assoc (2002) 0.90

Methamphetamine toxicity and messengers of death. Brain Res Rev (2009) 2.69

Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry (2010) 2.11

Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology (2002) 2.07

Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J Neurochem (2002) 1.99

The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: do they diagnose the same smokers? Addict Behav (2002) 1.74

Depression in African Americans: breaking barriers to detection and treatment. J Fam Pract (2006) 1.60

Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc Natl Acad Sci U S A (2005) 1.59

Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics (2005) 1.49

Sleep disturbance in heavy marijuana users. Sleep (2008) 1.49

Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug Alcohol Depend (2009) 1.40

Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J (2004) 1.39

Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage. Exp Neurol (2005) 1.31

A factor analysis of the Fagerström Test for Nicotine Dependence (FTND). Nicotine Tob Res (2003) 1.28

Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiol Dis (2008) 1.22

Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. PLoS One (2010) 1.22

p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Ann Neurol (2002) 1.19

Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res Brain Res Rev (2003) 1.17

Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learn Mem (2009) 1.16

CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat. Neurobiol Dis (2013) 1.10

Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. J Anal Toxicol (2009) 1.09

Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection. Psychopharmacology (Berl) (2011) 1.06

Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation/hypoacetylation in the rat nucleus accumbens. PLoS One (2012) 1.06

Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum. PLoS One (2009) 1.06

Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. Clin Chem (2009) 1.05

The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction. Hum Genet (2006) 1.05

Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges. J Neurochem (2008) 1.04

Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates. Biol Psychiatry (2009) 1.04

Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway. Neuropharmacology (2002) 1.03

Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain. J Neurochem (2002) 1.03

Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb. Biol Psychiatry (2006) 1.02

Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction (2010) 0.98

Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J Neurosci (2005) 0.98

Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway. FASEB J (2005) 0.98

Neonatal dopamine depletion induces changes in morphogenesis and gene expression in the developing cortex. Neurotox Res (2007) 0.98

Paroxetine retards disease onset and progression in Huntingtin mutant mice. Ann Neurol (2004) 0.98

Methamphetamine causes coordinate regulation of Src, Cas, Crk, and the Jun N-terminal kinase-Jun pathway. Mol Pharmacol (2002) 0.97

Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways. PLoS One (2011) 0.96

Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain. Brain Res (2004) 0.96

Mice with partial deficiency of c-Jun show attenuation of methamphetamine-induced neuronal apoptosis. Mol Pharmacol (2002) 0.93

Monoamine oxidases regulate telencephalic neural progenitors in late embryonic and early postnatal development. J Neurosci (2010) 0.92

Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence. Sleep Med (2010) 0.92

Environmental enrichment during adolescence regulates gene expression in the striatum of mice. Brain Res (2008) 0.91

Characteristics of African American teenage smokers who request cessation treatment: implications for addressing health disparities. Arch Pediatr Adolesc Med (2003) 0.91

Contribution of substance abuse and HIV infection to psychiatric distress in an inner-city African-American population. J Natl Med Assoc (2002) 0.90

Differential effects of methamphetamine and SCH23390 on the expression of members of IEG families of transcription factors in the rat striatum. Brain Res (2010) 0.89

Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model. Neuropharmacology (2011) 0.89

Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats. Psychopharmacology (Berl) (2008) 0.88

GluA3-deficiency in mice is associated with increased social and aggressive behavior and elevated dopamine in striatum. Behav Brain Res (2012) 0.88

Chronic methamphetamine increases fighting in mice. Pharmacol Biochem Behav (2004) 0.88

Analysis of ecstasy (MDMA)-induced transcriptional responses in the rat cortex. FASEB J (2002) 0.87

Chronic methamphetamine administration causes differential regulation of transcription factors in the rat midbrain. PLoS One (2011) 0.86

Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice. Neurosci Res (2009) 0.85

Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum. PLoS One (2012) 0.84

Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein. Neurobiol Aging (2012) 0.84

Epigenetic landscape of amphetamine and methamphetamine addiction in rodents. Epigenetics (2015) 0.83

(±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice. J Anal Toxicol (2011) 0.83

Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin. Behav Pharmacol (2014) 0.82

A marked increase in cocaine-related deaths in the State of Florida: precursor to an epidemic? J Addict Dis (2007) 0.81

Ceruloplasmin deficiency results in an anxiety phenotype involving deficits in hippocampal iron, serotonin, and BDNF. J Neurochem (2011) 0.81

Nicotine dependence criteria of the DIS and DSM-III-R: a factor analysis. Nicotine Tob Res (2004) 0.81

Attenuated response to methamphetamine sensitization and deficits in motor learning and memory after selective deletion of β-catenin in dopamine neurons. Learn Mem (2012) 0.80

Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review. J Addict Dis (2009) 0.80

Methamphetamine-induced gene expression profiles in the striatum of male rat pups exposed to the drug in utero. Brain Res Dev Brain Res (2003) 0.79

Methamphetamine-induced increase in striatal p53 DNA-binding activity is attenuated in Cu,Zn-superoxide dismutase transgenic mice. Neurosci Lett (2002) 0.78

The combination of methamphetamine and of the HIV protein, Tat, induces death of the human neuroblastoma cell line, SH-SY5Y. Synapse (2008) 0.78

Serial analysis of gene expression in the rat striatum following methamphetamine administration. Ann N Y Acad Sci (2006) 0.78

Amphetamine causes dopamine depletion and cell death in the mouse olfactory bulb. Eur J Pharmacol (2008) 0.78

Differential effects of environment-induced changes in body temperature on modafinil's actions against methamphetamine-induced striatal toxicity in mice. Neurotox Res (2014) 0.77

Dietary restriction mitigates cocaine-induced alterations of olfactory bulb cellular plasticity and gene expression, and behavior. J Neurochem (2010) 0.77

Ocular manifestations of crystal methamphetamine use. Neurotox Res (2009) 0.76

Altered spatial learning, cortical plasticity and hippocampal anatomy in a neurodevelopmental model of schizophrenia-related endophenotypes. Eur J Neurosci (2012) 0.76

Analysis of methamphetamine-induced changes in the expression of integrin family members in the cortex of wild-type and c-fos knockout mice. Neurotox Res (2003) 0.76

cDNA array analysis of gene expression profiles in the striata of wild-type and Cu/Zn superoxide dismutase transgenic mice treated with neurotoxic doses of amphetamine. FASEB J (2002) 0.76

Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatum. Neurotox Res (2009) 0.76

Correction: Chronic Methamphetamine Effects on Brain Structure and Function in Rats. PLoS One (2017) 0.75

Cerebral blood flow pulsatility deficits in HIV+ poly substance abusers: differences associated with antiviral medications. Drug Alcohol Depend (2002) 0.75

Ontogeny of neurokinin-1 receptor mediation of methamphetamine neurotoxicity in the striatum of the mouse brain. Ann N Y Acad Sci (2002) 0.75